Loading...
XSHG
603716
Market cap574mUSD
Dec 05, Last price  
21.32CNY
1D
0.99%
1Q
-25.58%
Jan 2017
-40.79%
IPO
75.04%
Name

Thalys Medical Technology Group Corp

Chart & Performance

D1W1MN
XSHG:603716 chart
P/E
P/S
2.24
EPS
Div Yield, %
Shrs. gr., 5y
-0.53%
Rev. gr., 5y
-0.22%
Revenues
1.81b
-9.74%
193,737,748283,166,616392,180,017445,045,201529,659,702627,328,056920,516,5441,317,446,0521,830,771,6162,125,471,6032,599,547,3482,308,631,6552,006,134,3341,810,681,362
Net income
-209m
L+31.95%
37,782,40038,330,98049,064,42456,518,10561,459,32768,917,86493,847,38594,159,095110,420,39482,034,68600-158,571,532-209,239,667
CFO
100m
-20.88%
-24,215,7002,699,20032,535,24030,065,36946,106,51100093,923,3649,944,111028,121,714125,886,03099,595,348
Dividend
Jun 18, 20200.08 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Thalys Medical Technology Group Inc. engages in the medical intensive business and operation services in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.
IPO date
Oct 31, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT